Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
life sciences
national blog main
san francisco blog main
3
×
boston top stories
cancer
clinical trials
fda
national
national top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
abbvie
accent therapeutics
actavalon
acute myeloid leukemia
aducanumab
aileron therapeutics
akouos
alzheimer's disease
amblyotech
aprea therapeutics
arimoclomol
arnold levine
asklepios biopharmaceutical
astellas pharmaceuticals
baker brothers
bioeurope
biogen
biomarin pharmaceutical
biotech ipos
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
What
developing
3
×
ipo
3
×
fda
medicines
activity
affects
americans
approvals
approved
bio
biogen
blood
broader
cancer
clamped
company
covid
date
delays
detect
drug
economic
fast
files
firms
frequency
grail
hearing
including
intended
investors
isn’t
join
life
loss
lot
meds
millions
new
oric’s
Language
unset
Current search:
biotech
×
developing
×
" san francisco blog main "
×
ipo
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds